News & Analysis on Clinical Trial Services & Contract Research And Development
The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical, medical device and diagnostics manufactures to identify failures early, in order to minimize costs, and to complete clinical trials as safely, efficiently and quickly as possible, while maintaining high quality, accuracy, completeness and integrity of the clinical data.
Paid for and content provided by PerkinElmer
Challenges abound with typical clinical data review. Here’s how to avoid them so that you can maintain control throughout the process.
Paid for and content provided by PerkinElmer
Trials can often experience impediments great and small. Here’s how unified analytics platforms can provide real-time data for more accurate, expedient review.
With a portfolio of clinical studies that fluctuates year over year depending on the portfolio, resource and cost constraints are a constant issue. Questions such as how many patients will participate in clinical studies? How will the studies be paid...
At Novartis, TIBCO Spotfire® enterprise analytics is a key tool for interactive graphical data analysis for preclinical and clinical studies. Using interactive graphical data exploration provides an efficient, powerful, and flexible tool to improve...
For more product information visit PerkinElmer.